((自动化翻译由路透提供，请见免责声明 ))
9月11日 - ** 生物技术公司Applied DNA Sciences 股价上涨37.66%至1.76美元
** 该公司称， (link)，其部门Applied DNA Clinical Labs已开始扩大其检测mpox的临床测试服务，包括I系和II系变体的测试。
** 该部门的检测方法曾于 2022 年 9 月被纽约州卫生部批准为实验室开发的检测水痘支系 II 的检测方法。
** 一种新型病毒引发了全球关注，因为它似乎很容易通过日常密切接触传播，促使卫生机构在 8 月宣布 (link) mpox 为全球公共卫生紧急事件。
** 天花病毒会导致类似流感的症状和身体化脓性病变，并通过接触传播
** 今年以来股价下跌约 85
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.